Number of Shares
12,731.00
Current Holdings Value*
$1.42 Mil
% of Portfolio
3.28%
Total Estimate Gain
$145,951.36
% of Total Estimate Gain
8.48%

AlphaCentric Life Sciences and Healthcare Fund's Novartis AG Holding Summary

As of 2025-03-31, AlphaCentric Life Sciences and Healthcare Fund held 12,731.00 shares of Novartis AG(NVS), totaling $1.42 Mil. This investment constitutes 3.28% of their stock portfolio, and AlphaCentric Life Sciences and Healthcare Fund now holds 0% of the outstanding Novartis AG(NVS) stock.

The initial trade took place in 2020Q2. And since then AlphaCentric Life Sciences and Healthcare Fund has made 2 purchases of NVS, at an average price of $105.83, for a total of 16,269.00 shares. In addition, there have been 2 sales at an average price of $103.38 for 3,538.00 shares. Based on historical transaction data and NVS's current price of $117.97, AlphaCentric Life Sciences and Healthcare Fund's estimated gain on his NVS holdings is $145,951.36, reflecting a 8.48% gain to date.

AlphaCentric Life Sciences and Healthcare Fund NVS ($117.97) Holding Chart

AlphaCentric Life Sciences and Healthcare Fund NVS ($117.97) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1